HemaSphere (Jun 2022)
P1024: IMPACT OF TP53 IN MYELOFIBROSIS UNDERGOING STEM CELL TRANSPLANTATION
- N. Gagelmann,
- A. Badbaran,
- V. Panagiota,
- C. Wolschke,
- F. Ayuk,
- F. Thol,
- M. Ditschkowski,
- B. Cassinat,
- M. Robin,
- T. Schroeder,
- M. Heuser,
- H. C. Reinhardt,
- N. Kröger
Affiliations
- N. Gagelmann
- 1 University Medical Center Hamburg-Eppendorf, Hamburg
- A. Badbaran
- 1 University Medical Center Hamburg-Eppendorf, Hamburg
- V. Panagiota
- 2 Medical School Hannover, Hannover
- C. Wolschke
- 1 University Medical Center Hamburg-Eppendorf, Hamburg
- F. Ayuk
- 1 University Medical Center Hamburg-Eppendorf, Hamburg
- F. Thol
- 2 Medical School Hannover, Hannover
- M. Ditschkowski
- 3 University Hospital Essen, Essen, Germany
- B. Cassinat
- 4 APHP, Paris, France
- M. Robin
- 4 APHP, Paris, France
- T. Schroeder
- 3 University Hospital Essen, Essen, Germany
- M. Heuser
- 2 Medical School Hannover, Hannover
- H. C. Reinhardt
- 3 University Hospital Essen, Essen, Germany
- N. Kröger
- 1 University Medical Center Hamburg-Eppendorf, Hamburg
- DOI
- https://doi.org/10.1097/01.HS9.0000846964.70693.96
- Journal volume & issue
-
Vol. 6
pp. 914 – 915
Abstract
No abstracts available.